Keywords: boeh, ingl, initiates, viramune, study, german, drug

Boeh Ingl initiates US Viramune study

Article | 10 December 2007

Print This

German drug major Boehringer Ingelheim has begun to enroll HIV patients in the NEwArT study to include 18 planned sites across ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in